Financial statements Ngk Pharma
Balance sheet of Ngk Pharma
Company age:
Age:
5 y. 10 m. 10 d.
Share capital:
Share capital:
60 000 PLN
Balance sheet data of NGK PHARMA
|
Year
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|
| Total assets | 1 628 067,94 | 1 789 420,55 | 4 274 875,20 | 14 756 776,08 |
| A. Fixed assets | 1 014 217,62 | 966 375,83 | 932 103,60 | 1 628 855,02 |
| B. Current assets | 613 850,32 | 823 044,72 | 3 342 771,60 | 13 127 921,06 |
| C. Share capital contributions (basic funds) | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - |
| Total liabilities | 1 628 067,94 | 1 789 420,55 | 4 274 875,20 | 14 756 776,08 |
| A. Equity | 608 624,78 | 780 664,69 | 1 427 569,97 | 10 639 635,22 |
| B. Liabilities and provisions for liabilities | 1 019 443,16 | 1 008 755,86 | 2 847 305,23 | 4 117 140,86 |
| I. Long-term liabilities | 129 116,29 | 114 620,63 | 0,00 | 0,00 |
| II. Short-term liabilities | 890 326,87 | 894 135,23 | 2 238 778,54 | 4 117 128,06 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.